AOP Health Receives Market Authorization for Landiolol in Canada

At the end of November 2023, AOP Orphan Pharmaceuticals GmbH (AOP Health), an Austrian pharmaceutical company based in Vienna, received authorization from the Canadian Health Authority (Health Canada) for its ultra-short-acting, cardioselective...

Related Keywords

Vienna ,Wien ,Austria ,Canada ,United States ,Austrian ,American ,Canadian ,Martin Steinhart ,Product Service ,Health Group ,Health Corporate Alliance ,Health Receives Market Authorization For Landiolol ,Trimedic Therapeutics Inc ,Canadian Health Authority Canada ,Pharmaceuticals Gmb ,Receives Market Authorization ,Pharmaceuticals Gmbh ,Canadian Health Authority ,Health Canada ,North American ,Trimedic Therapeutics ,Corporate Alliance Director ,Middle East ,